875 related articles for article (PubMed ID: 24687388)
1. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
2. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
3. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
[TBL] [Abstract][Full Text] [Related]
4. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
5. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
6. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
[TBL] [Abstract][Full Text] [Related]
7. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
8. Tubular biomarkers to assess progression of diabetic nephropathy.
Tramonti G; Kanwar YS
Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
[TBL] [Abstract][Full Text] [Related]
9. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Bonventre JV; Sabbisetti V; Waikar SS; Mifflin TE; Zhang X; Xie D; Hsu CY; Feldman HI; Coresh J; Vasan RS; Kimmel PL; Liu KD;
Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
[TBL] [Abstract][Full Text] [Related]
10. Glomerular and tubular damage markers are elevated in patients with diabetes.
Nauta FL; Boertien WE; Bakker SJ; van Goor H; van Oeveren W; de Jong PE; Bilo H; Gansevoort RT
Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
[TBL] [Abstract][Full Text] [Related]
12. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
Noyan A; Parmaksiz G; Dursun H; Ezer SS; Anarat R; Cengiz N
J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
[TBL] [Abstract][Full Text] [Related]
13. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
15. Analysis of a urinary biomarker panel for obstructive nephropathy and clinical outcomes.
Xie Y; Xue W; Shao X; Che X; Xu W; Ni Z; Mou S
PLoS One; 2014; 9(11):e112865. PubMed ID: 25402279
[TBL] [Abstract][Full Text] [Related]
16. Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation.
Koo TY; Jeong JC; Lee Y; Ko KP; Lee KB; Lee S; Park SJ; Park JB; Han M; Lim HJ; Ahn C; Yang J
Medicine (Baltimore); 2016 Mar; 95(11):e3076. PubMed ID: 26986138
[TBL] [Abstract][Full Text] [Related]
17. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.
Parmaksız G; Noyan A; Dursun H; İnce E; Anarat R; Cengiz N
Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
Chou KM; Lee CC; Chen CH; Sun CY
PLoS One; 2013; 8(1):e54863. PubMed ID: 23349979
[TBL] [Abstract][Full Text] [Related]
19. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy].
Wang L; Pu X
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB
Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
